Literature DB >> 534868

Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.

F E Preston, J F Martin, R M Stewart, G A Davies-Jones.   

Abstract

In 12 patients whose neurological dysfunction was associated with thrombocytosis or evidence of abnormal platelet activation, or both, correction of the platelet disorder corresponded with reversal of the neurological symptoms. This suggests that platelet abnormalities may, in certain cases, produce several syndromes of neurological dysfunction, presumably as a result of obstruction of the cerebral microcirculation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 534868      PMCID: PMC1597479          DOI: 10.1136/bmj.2.6204.1561

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.

Authors:  K K Wu; J C Hoak
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  Quantitation of in vivo platelet aggregation by the platelet aggregate ratio method.

Authors:  T S Burns; R N Saunders
Journal:  Thromb Res       Date:  1977-04       Impact factor: 3.944

4.  Rebound thrombocytosis after alcohol abuse: a possible factor in the pathogenesis of thromboembolic disease.

Authors:  E M Haselager; J Vreeken
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

5.  Increased platelet aggregates in patients with transient ischemic attacks.

Authors:  K K Wu; J C Hoak
Journal:  Stroke       Date:  1975 Sep-Oct       Impact factor: 7.914

6.  Platelet abnormalities in diabetic peripheral neuropathy.

Authors:  C B O'Malley; J D Ward; W R Timperley; N R Porter; F E Preston
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

  6 in total
  13 in total

1.  Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue.

Authors:  W Martin; T Spyt; I Thomas; J F Davidson; D J Wheatley
Journal:  Eur J Nucl Med       Date:  1989

2.  Regional cerebral blood flow (rCBF) and cerebral vasoreactivity in patients with retinal ischaemic symptoms.

Authors:  E Kerty; D Russell; S J Bakke; R Nyberg-Hansen; K Rootwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

3.  Studies on platelets before and after stroke in a patient with essential thrombocythaemia.

Authors:  S Heptinstall; S R Cockbill; M E Burgess-Wilson; E W Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

4.  Platelets, alcohol consumption, and onset of brain infarction.

Authors:  H Numminen; M Hillbom; S Juvela
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Superior sagittal sinus thrombosis and essential thrombocythaemia.

Authors:  M F Murphy; C R Clarke; R L Brearley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

6.  Amaurosis fugax.

Authors:  W Pryse-Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16

7.  Essential thrombocytemia and ischemic stroke: report of six cases.

Authors:  L Casto; M Camerlingo; G Finazzi; B Censori; T Barbui; A Mamoli
Journal:  Ital J Neurol Sci       Date:  1994-10

8.  [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].

Authors:  M Jahn; B Zönnchen; W Köpcke; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01

9.  Bilateral retinal artery occlusion due to mitral valve prolapse.

Authors:  F van Rhee; T E Blecher; K A DeLepeleire; N R Galloway
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

10.  The causes of stroke in the young.

Authors:  D Hilton-Jones; C P Warlow
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.